Vertex Pharmaceuticals (VRTX) Minority Interest (2011 - 2018)

Vertex Pharmaceuticals' Minority Interest history runs 8 years deep, the most recent figure standing at $28.4 million for Q3 2018.

• In Q3 2018, Minority Interest rose 133.13% year-over-year to $28.4 million; the TTM figure through Sep 2018 stood at $28.4 million (up 133.13% YoY), while the FY2017 annual figure was $13.7 million, down 92.44% from the prior year.
• Minority Interest was $28.4 million for Q3 2018 at Vertex Pharmaceuticals, down from $28.7 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $196.0 million in Q2 2017 to a low of $12.2 million in Q3 2017.
• Historically, Minority Interest has averaged $106.9 million across 5 years, with a median of $153.5 million in 2015.
• The sharpest annual moves came in 2016 and 2017: Minority Interest soared 654.87% in 2016, then plunged 93.49% in 2017.
• A 5-year view of Minority Interest shows it stood at $21.2 million in 2014, then soared by 625.6% to $153.7 million in 2015, then advanced by 18.19% to $181.6 million in 2016, then sank by 92.44% to $13.7 million in 2017, then soared by 106.64% to $28.4 million in 2018.
• The last three Minority Interest figures came in at $28.4 million (Q3 2018), $28.7 million (Q2 2018), and $29.8 million (Q1 2018), per Business Quant data.